Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Counselor/Therapist: Registration

Counselor imageDrug and Alcohol Counselors and Therapists,
Behavioral therapy has been shown to be an essential component of addiction treatment. Unfortunately, patients sometime cannot find a counselor or therapist familiar or willing to treat patients employing certain evidence-based addiction treatments including medications.
We are compiling an online locator to help connect patients seeking behavioral therapy, with counselors and therapists that have an evidence-based philosophy of treatment, and are familiar with modern treatments.
We invite you to register for our locator that will be shared with other advocacy organizations nationwide to help patients find the help they need. There is no cost and you can remove your listing at any time.
Registered counselors can login on the Counselor Resource Page to update the information displayed on our locator.
Resource Packet including CD
Please send resource packet including CD 
e-newsletter
Please sign me up for your e-newsletter 
  * = Required for inclusion in the counselor/therapist locator on NAABT.org or to receive the NAABT e-newsletter.
(200 Character Max)

Characters Left
  To allow future access to your account for editing purposes:
OFFICE USE ONLY
(will not be displayed on NAABT.org):

    

Buprenorphine Education Learn more about
Opioid Addiction and
the Buprenorphine
Treatment Option
  Local
Resources
Find a Physician
certified to prescribe
Buprenorphine
  National Alliance of Advocates for Buprenorphine Treatment Go to naabt.org
home page
This page was last modified on : 02/10/2010
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.